More on TNYA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (5/7/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Tenaya Therapeutics (NQ:TNYA)
Delayed: 0.89 +0.07 (8.54%)
Prev. Close $0.82  
Open$0.78 
52 Wk High$ 
52 Wk Low$ 
Day High$0.92 
Day Low$0.73 
P/E N/A  
EPS$ 
Volume11,322,427 


Mar 5, 2026 08:35 AM Form 8-K Tenaya Therapeutics, For: Mar 04
Mar 5, 2026 08:31 AM Tenaya Therapeutics partners with Alnylam for heart disease targets
Mar 5, 2026 08:30 AM Tenaya Therapeutics Enters into Research Collaboration with Alnylam Pharmaceuticals to Identify and Validate Novel Genetic Targets for Cardiovascular Disease Therapeutics
Mar 2, 2026 04:05 PM Tenaya Therapeutics to Participate in the Leerink Partners Global Healthcare Conference 2026
Feb 26, 2026 04:36 PM Form SCHEDULE 13D/A Tenaya Therapeutics, Filed by: COLUMN GROUP III, LP
Feb 26, 2026 04:31 PM Form 4 Tenaya Therapeutics, For: Feb 24 Filed by: Column Group Opportunity III, LP
Feb 25, 2026 05:06 PM Form 144 Tenaya Therapeutics, Filed by: COLUMN GROUP III, LP
Feb 25, 2026 05:05 PM Form 144 Tenaya Therapeutics, Filed by: COLUMN GROUP III-A, LP
Feb 24, 2026 04:14 PM Form 4 Tenaya Therapeutics, For: Feb 20 Filed by: Svennilson Peter
Feb 20, 2026 05:37 PM Form 144 Tenaya Therapeutics, Filed by: COLUMN GROUP III, LP
View All Articles

Entities mentioned with TNYA

View All Entities